Don’t let the high cost of brand pediatric mTOR inhibitor disrupt your child’s tuberous sclerosis complex or SEGA treatment. We help eligible families access Afinitor Disperz (everolimus tablets for oral suspension) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.

The Afinitor Disperz Patient Assistance Program helps eligible families access this pediatric everolimus for TSC at little or no cost when meeting income, insurance, and clinical criteria. Free to apply but involves detailed applications, neurology/genetics coordination, and renewal.
At AffordMyPrescriptions, our Patient Advocates handle the entire Afinitor Disperz PAP enrollment for a flat $69.95 per month — so families never face a gap in Afinitor Disperz therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Afinitor Disperz enrollment — so families never face a gap in TSC treatment.
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Sirolimus generic (off-label) | ~$300/mo | Related mTOR generic |
| Specialty pharmacy | ~$15,000/mo | Save substantially |
| Walgreens Specialty | ~$16,000/mo | Save substantially |
| CVS Specialty | ~$17,000/mo | Save substantially |
| 340B-eligible institution | ~$13,000/mo | Save substantially |
| Everolimus generic (adult tabs) | ~$5,000/mo | Adult tablet alt if suitable |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Afinitor Disperz — independent of dosage or retail price.

1 Medications

2 Medications

3 Medications

4+ Medications
The Afinitor Disperz Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. TSC is complex — care through TSC specialty clinics or neurology, epilepsy, and genetics coordination optimizes outcomes. Multiple therapeutic options exist for TSC-associated seizures and SEGA.
Complete a simple eligibility form so our team can determine if you may qualify for Afinitor Disperz assistance.
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Once approved, your Afinitor Disperz is delivered through the assistance program while we manage refills and annual renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Afinitor Disperz:
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $15,000+ per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Fixed $69.95/month — never changes regardless of retail price
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Afinitor Disperz assistance.
Afinitor Disperz is the pediatric everolimus formulation (tablets for oral suspension) — an mTOR inhibitor for tuberous sclerosis complex-associated SEGA and refractory partial-onset seizures. The pediatric formulation enables age-appropriate dosing.
How It Works:
Tuberous sclerosis complex (TSC) is a genetic disorder caused by mutations in TSC1 or TSC2 — leading to hyperactivation of the mTOR signaling pathway. It causes benign tumors (hamartomas) in multiple organs including brain (SEGA — subependymal giant cell astrocytoma; cortical tubers), kidney (angiomyolipomas), heart, skin, and lungs. Neurological manifestations include seizures (~85% of patients — often refractory), intellectual disability, and autism spectrum disorder. Everolimus is an mTOR inhibitor targeting the core pathological pathway of TSC — reducing SEGA volume, angiomyolipomas, and seizure frequency. The pediatric formulation enables dosing by body surface area with therapeutic drug monitoring.
Form and Use:
Afinitor Disperz tablets for oral suspension (2 mg, 3 mg, 5 mg). Dose based on body surface area and therapeutic drug monitoring (target trough level). Disperse tablets in water; administer via oral syringe. Adjust dose based on plasma levels and side effects.
Generic Availability:
No generic Afinitor Disperz. Adult everolimus tablets are available generic. Related product: Afinitor (everolimus tablets — brand and generic; for adult oncology and adult TSC). Related mTOR inhibitor: sirolimus (Rapamune — generic; used off-label for TSC — may be more affordable). Alternative TSC therapies: surgical resection for select SEGAs, standard antiepileptic drugs (levetiracetam/Keppra generic, lamotrigine, oxcarbazepine), vigabatrin (Sabril — first-line for infantile spasms in TSC), ketogenic diet, and epilepsy surgery for refractory epilepsy. Tuberous Sclerosis Alliance provides patient resources and a TSC clinic directory.
Warnings:
Non-infectious pneumonitis (can be severe — monitor for respiratory symptoms and imaging), infections (bacterial, viral, fungal — hepatitis B reactivation, tuberculosis; opportunistic infections), stomatitis (very common — mouth ulcers), embryo-fetal toxicity (contraindicated in pregnancy), impaired wound healing (hold before elective surgery), thrombotic microangiopathy (rare), renal failure, hyperlipidemia and hyperglycemia (monitor), decreased blood counts (monitor CBC), angioedema (increased with ACE inhibitors — avoid combination). Other: fatigue, headache, rash, hypertension, elevated LFTs. CYP3A4 substrate — many drug interactions. Therapeutic drug monitoring essential. TSC specialty clinic follow-up.
$15,000+ per month at specialty pharmacies. Adult everolimus tablets (generic) cost $4,000–$6,000/month. Sirolimus (Rapamune generic — related mTOR inhibitor sometimes used off-label for TSC) is $200–$400/month generic — a significantly cheaper alternative in some cases.
Same molecule (everolimus). Afinitor is the standard tablet for adults. Afinitor Disperz is dispersible tablets for oral suspension for pediatric use — age-appropriate dosing by body surface area. Both are for TSC-associated SEGA and refractory partial-onset seizures. Adult Afinitor tablets have additional oncology indications.
TSC is caused by mutations in TSC1 or TSC2 genes — leading to hyperactivation of the mTOR signaling pathway. Everolimus is an mTOR inhibitor targeting the core molecular defect. It reduces SEGA tumor volume, renal angiomyolipomas, and TSC-associated seizure frequency — precision therapy addressing underlying pathophysiology.
An individual decision by the neurosurgery/neurology team. Some SEGAs are amenable to surgical resection (curative); others (large, deep, or bilateral) benefit more from everolimus. Everolimus can shrink SEGA and may enable subsequent surgery or avoid it. Coordinated TSC clinic care optimizes decision-making.
Stomatitis (mouth ulcers — very common), infections (including opportunistic), non-infectious pneumonitis (can be severe), fatigue, rash, headache, hyperlipidemia, hyperglycemia, cytopenias, elevated LFTs, hypertension, impaired wound healing. Requires therapeutic drug monitoring. TSC specialty clinic care recommended.
Precision therapy for tuberous sclerosis complex addresses underlying molecular pathophysiology. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.